Author:
Johnston Kelly,Casstevens Cristina,Patel Vanessa Perez,Merikle Elizabeth,Presnall Carrie,Audhya Ivana
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference42 articles.
1. World Health Organization. World Health Organization. International Classification of Diseases version 11. 8C70.4 Limb girdle muscular dystrophy [Internet]. 2019. http://id.who.int/icd/entity/887807212
2. Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, et al. A journey with LGMD: from protein abnormalities to patient impact. Protein J. 2021;40(4):466–88.
3. Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, et al. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43:259–68.
4. Deenen JCW, Horlings CGC, Verschuuren JJGM, Verbeek ALM, Van Engelen BGM. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. Journal of Neuromuscular Diseases. 2015;2:73–85.
5. Liu W, Pajusalu S, Lake NJ, Zhou G, Ioannidis N, Mittal P, et al. Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genet Med. 2019;21(11):2512–20.